Jacob Grønnegaard of FujiFilm Diosynth Biotechnologies discussed how the company’s unique cloning processes dramatically reduce project execution time, effort and expense at Emerson Exchange Immerse event. The result is intended to be one of the top medicine production facilities in the country. Hopefully, it won’t have to ramp up production for a virus vaccine to combat a worldwide pandemic, but if the time ever comes again, it will be scalable and ready.
Latest News
Emerson Software Helps Covestro Increase Operational Efficiency and Sustainability
Advanced process control increases polyester production throughput by 1% and improves energy efficiency while reducing water consumption
New Emerson Pressure Regulator Maximizes Hydrogen-Powered Vehicle Fuel Efficiency, Improves...
With a contamination-resistant design, the TESCOM HV-7000 Series provides stable pressure delivery in all flow conditions with a longer service life
Emerson Now Accepting Applications for 2024-2025 Discrete Automation Scholarship
Two academic merit award winners will receive financial support and grants for collegiate STEM research and educational programs
